News

Press Releases

Inflection Biosciences to Present at BioTrinity 2015

Dublin, Ireland, April 27, 2015 – Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Inflection Biosciences Appoints John Lynch to its Board of Directors

Dublin, Ireland, March 16, 2015 Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Inflection Biosciences Raises €725,000 in Second Financing Round

Dublin, Ireland, March 9, 2015 Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Multiple Myeloma Research Foundation & Inflection Biosciences Collaborate on a New Cancer Treatment

Dublin, Ireland, February 9, 2015 Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Inflection Biosciences Announces Pre-clinical Data to be Presented at the ASH 2014 Annual Meeting

Dublin, Ireland, December 3rd, 2014 – Inflection Biosciences Ltd, a private company developing novel targeted small molecule therapeutics...

Inflection Biosciences Named Start-up Company of the Year at the Pharma Industry Awards 2014

Dublin, Ireland, November 3, 2014 Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Inflection Biosciences Announces Research Collaboration with Trinity College Dublin

Dublin, Ireland, October 30, 2014 Inflection Biosciences Ltd, a private company developing targeted small molecule treatments for cancer,...

Inflection Biosciences Shortlisted for The Pharma Industry Awards 2014

Dublin, Ireland, October 1, 2014 Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Inflection Biosciences to Present at Annual BioPharm America International Partnering Conference

Dublin, Ireland, September 15, 2014 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...

Inflection Biosciences Announces Poster Presentation at the 2014 AACR Annual Meeting

Dublin, Ireland, March 24, 2014 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...